Assyro AI

FDA Orange Book · active-ingredient family

Epinephrine bitartrate

Epinephrine bitartrate is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

3

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · aerosol, metered, solution

ProductApplicantApplicationTEApproved
EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDERLD×2BAXTER HLTHCARE CORPNDA 218475Mar 16, 2026
BRONITIN MISTWYETH CONSNDA 016126Approved Prior to Jan 1, 1982
MEDIHALER-EPI3MNDA 010374Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Epinephrine bitartrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.